← Leaderboards
Arthur S. Rovner
Haematologic Technologies, Inc.
$180,171
Attributed
$180,171
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$180,171 · 1
By mechanism
R43$180,171 · 1
Top collaborators
No co-investigators on record.
Most similar at Haematologic Technologies, Inc.
Same institution · by research overlap
- Richard J. Jenny$1,204,660
- Ryan H Dorfman$756,228
Others in their field
Other Emerging Leaders on “Adverse Outcome”
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Kristin Aillon · Midwest Research Institute$25,857,783
- Abraham Aizer Brody · New York University School Of Medicine$21,887,280
- Ellen Gould Chadwick · Harvard University D/B/A Harvard School Of Public Health$21,828,548
- Barbara Halina Braffett · George Washington University$18,816,779
- Ionut Bebu · George Washington University$18,816,779
Research focus
Adverse OutcomeAnticoagulantsAntiplatelet DrugsAntithrombin IiiAssessment ToolAtrial FibrillationBloodBlood CoagulationBlood Coagulation TestsBlood PlateletsBlood SpecimenCardiovascular DiseasesCardiovascular SystemChronicClinical RiskCoagulation ProcessCollectionDetectionDiagnosticDietDosageDoseDrug KineticsAcute